- three are already already being tested in human trials
- Hong Kong-listed CanSino Biologics
- Beijing Institute of Biotechnology
- US’ Moderna and Inovio Pharmaceuticals
- Pfizer and Sanofi also
China Vice Technology Minister Xu says that the fastest a coronavirus vaccine to be submitted for clinical trials will be around late April
The Coronavirus continues to see an outbreak globally with the latest estimates putting the death total over 900 persons. With fear continuing to spread and millions disrupted, financial markets have certainly been impacted.
Typically, most problematic geo-political or economic events have always managed to yield some material effect on markets. This was seen earlier this year with the rising tensions between the US and Iran.
However, the Coronavirus is itself an entirely different animal, whose impact is far more globally reaching. This article will explore how the virus has correlated to financial markets and which instruments should be looked at.